Tiny blood cells could hold key to brain tumor treatment

NCT ID NCT05049148

Recruiting now Knowledge-focused Sponsor: Fondation Ophtalmologique Adolphe de Rothschild Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study looks at whether platelets—small blood cells that help with clotting—are found inside brain and spinal cord tumors. Researchers want to see if the presence of platelets in these tumors is linked to how long patients survive. The study will involve 50 adults who are having surgery to remove or biopsy a brain or spinal cord tumor. The goal is to better understand the tumor environment and possibly find new targets for therapy.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If this study finds that platelets are important in brain tumor growth, it could point toward new ways to improve cancer treatments.
What could go wrong: This is a small, early observational study with only 50 people. It is not testing a treatment, so it may not lead to any direct benefit for patients.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for BLOOD PLATELETS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

blood platelet disease brain cancer brain neoplasm central nervous system cancer glioma Inflammation inflammatory disease spinal cord neoplasm

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

BLOOD PLATELETS BRAIN NEOPLASMS GLIOMA INFLAMMATION

Contacts and locations

Locations

Fondation A De Rothschild
RECRUITING

Paris, France

More trials for these conditions

Other studies related to the condition(s) this trial covers.